Media Summary: The Edmond J Safra Accelerating Clinical Trials for Parkinson's Disease ( Georg Mills I'm the research project manager for EGS Led by Professor Tom Foltynie from University College London and Professor Camille Carroll from Newcastle University, The ...

Ejs Act Pd The Multi - Detailed Analysis & Overview

The Edmond J Safra Accelerating Clinical Trials for Parkinson's Disease ( Georg Mills I'm the research project manager for EGS Led by Professor Tom Foltynie from University College London and Professor Camille Carroll from Newcastle University, The ... Project co-leads, Prof. Tom Foltynie and Dr Camille Carroll provide an overview 논문명: Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the

Photo Gallery

EJS ACT-PD: the world's largest clinical trial for Parkinson's
EJS-ACT-PD: The multi-arm, multi-stage clinical trials platform for Parkinson's - Georgia Mills
EJS ACT-PD clinical trial: the biggest ever clinical trial for Parkinson’s in the UK
EJS ACT-PD: how to get involved – Georgia Mills
EJS ACT-PD: Interview with the project Co-leads, Prof. Tom Foltynie & Dr Camille Carroll
What is EJS ACT-PD? Dr Camille Carroll & Prof. Tom Foltynie explain
PD Frontline webinar (Trials and the PD Community) - EJS ACT-PD
Georgia Mills: EJS ACT-PD: A MAMS UK Platform Trial to Accelerate Research for Parkinson’s
Accelerating Clinical Trials of Parkinson's treatments: Camille Carroll explains ACT-PD ...
SURE-PD3, a clinical trial to slow the decline of Parkinson’s disease
“세계 최대 파킨슨병 임상시험 EJS ACT-PD,어떤 지표로 ‘진행 억제’를 증명할까”
Webinar: Advancing Parkinson's trial designs
View Detailed Profile
EJS ACT-PD: the world's largest clinical trial for Parkinson's

EJS ACT-PD: the world's largest clinical trial for Parkinson's

The Edmond J Safra Accelerating Clinical Trials for Parkinson's Disease (

EJS-ACT-PD: The multi-arm, multi-stage clinical trials platform for Parkinson's - Georgia Mills

EJS-ACT-PD: The multi-arm, multi-stage clinical trials platform for Parkinson's - Georgia Mills

Georg Mills I'm the research project manager for EGS

EJS ACT-PD clinical trial: the biggest ever clinical trial for Parkinson’s in the UK

EJS ACT-PD clinical trial: the biggest ever clinical trial for Parkinson’s in the UK

We spoke with Director

EJS ACT-PD: how to get involved – Georgia Mills

EJS ACT-PD: how to get involved – Georgia Mills

Led by Professor Tom Foltynie from University College London and Professor Camille Carroll from Newcastle University, The ...

EJS ACT-PD: Interview with the project Co-leads, Prof. Tom Foltynie & Dr Camille Carroll

EJS ACT-PD: Interview with the project Co-leads, Prof. Tom Foltynie & Dr Camille Carroll

Laurel, one

What is EJS ACT-PD? Dr Camille Carroll & Prof. Tom Foltynie explain

What is EJS ACT-PD? Dr Camille Carroll & Prof. Tom Foltynie explain

Project co-leads, Prof. Tom Foltynie and Dr Camille Carroll provide an overview

PD Frontline webinar (Trials and the PD Community) - EJS ACT-PD

PD Frontline webinar (Trials and the PD Community) - EJS ACT-PD

A clip from the

Georgia Mills: EJS ACT-PD: A MAMS UK Platform Trial to Accelerate Research for Parkinson’s

Georgia Mills: EJS ACT-PD: A MAMS UK Platform Trial to Accelerate Research for Parkinson’s

Early career researchers share the focus

Accelerating Clinical Trials of Parkinson's treatments: Camille Carroll explains ACT-PD ...

Accelerating Clinical Trials of Parkinson's treatments: Camille Carroll explains ACT-PD ...

To say that the pace

SURE-PD3, a clinical trial to slow the decline of Parkinson’s disease

SURE-PD3, a clinical trial to slow the decline of Parkinson’s disease

SURE-PD3 is a clinical trial

“세계 최대 파킨슨병 임상시험 EJS ACT-PD,어떤 지표로 ‘진행 억제’를 증명할까”

“세계 최대 파킨슨병 임상시험 EJS ACT-PD,어떤 지표로 ‘진행 억제’를 증명할까”

논문명: Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the

Webinar: Advancing Parkinson's trial designs

Webinar: Advancing Parkinson's trial designs

... the project manager for

Learnings from clinical trial failure in Parkinson's disease

Learnings from clinical trial failure in Parkinson's disease

Joaquim Ferreira, MD, PhD, University